NFKB1 and hepatocellular carcinoma: Recently, NM has been shown to potently inhibit canonical NF-κB pathways and further suppress the aggressive behavior of various cancer, such as pancreatic cancer (12–14), colorectal (15), gastric (16), and hepatocellular carcinoma (17).